In The Media

Kevin A. O’Connor Quoted in IPPro Patents

Kevin A. O’Connor was quoted in the IPPro Patents article "Changes to Generic Drug Processes Should Be 'Carefully Assessed,'" published on February 2, 2018. The article discusses the potential impact on pharmaceutical innovation if the FDA adopts changes to bolster the generic drug market.

Click here to read the article.